Yunjian

The AI engine Fit Assessment

Beta

Yunjian leverages machine learning and big data to discover disease markers and expand therapeutics, demonstrating a strong fit for the requirements.

Blurb

Yunjian is a metabolomics- and protein-based marker-finding technology.

HQ Location

Hangzhou (China)

Founded

2015

Employees

11 - 50

Total funding raised

$1.29M

Funding Status

Series B, August 19, 2022
Subspaces
  • Biomarker Identification

Yunjian is a new generation of metabolomics- and protein-based marker-finding technologies. has developed a distinctive analytic platform based on mass spectrometry proteomics and big data, driven by medical theories that greatly reduce the time required by conventional methods to find disease markers. has a wealth of experience in big data illness models, medication development, disease biomarker identification, clinical translation and diagnostics, and data security.